358 related articles for article (PubMed ID: 23517034)
21. Recurrent angioedema: diagnosis strategy and biological aspects.
Bouillet L; Boccon-Gibod I; Berard F; Nicolas JF
Eur J Dermatol; 2014; 24(3):293-6. PubMed ID: 24723651
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
Castelli R; Zanichelli A; Cugno M
Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):181-90. PubMed ID: 23137231
[TBL] [Abstract][Full Text] [Related]
23. Laboratory Approaches for Assessing Contact System Activation.
Christiansen SC; Zuraw BL
Immunol Allergy Clin North Am; 2017 Aug; 37(3):527-539. PubMed ID: 28687107
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema.
Wilkerson RG; Winters ME
Immunol Allergy Clin North Am; 2023 Aug; 43(3):513-532. PubMed ID: 37394257
[TBL] [Abstract][Full Text] [Related]
25. Update on bradykinin-mediated angioedema in 2020.
Lepelley M; Bernardeau C; Defendi F; Crochet J; Mallaret M; Bouillet L
Therapie; 2020 Apr; 75(2):195-205. PubMed ID: 32113689
[TBL] [Abstract][Full Text] [Related]
26. Angioedema Due to Bradykinin Dysregulation.
Cicardi M; Zuraw BL
J Allergy Clin Immunol Pract; 2018; 6(4):1132-1141. PubMed ID: 30033914
[TBL] [Abstract][Full Text] [Related]
27. [Angioedema and the role of bradykinins: new treatments and implications in patients with heart failure].
Mansi M; Wu MA; Zanichelli A; Cicardi M
G Ital Cardiol (Rome); 2016 Dec; 17(12):966-972. PubMed ID: 28151501
[TBL] [Abstract][Full Text] [Related]
28. Evaluation and Management of Angioedema in the Emergency Department.
Long BJ; Koyfman A; Gottlieb M
West J Emerg Med; 2019 Jul; 20(4):587-600. PubMed ID: 31316698
[TBL] [Abstract][Full Text] [Related]
29. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress.
Cugno M; Zanichelli A; Foieni F; Caccia S; Cicardi M
Trends Mol Med; 2009 Feb; 15(2):69-78. PubMed ID: 19162547
[TBL] [Abstract][Full Text] [Related]
30. [Classification and pathophysiology of angioedema].
Buttgereit T; Maurer M
Hautarzt; 2019 Feb; 70(2):84-91. PubMed ID: 30506093
[TBL] [Abstract][Full Text] [Related]
31. [Emergency management of acute angioedema].
Bas M; Greve J; Bier H; Knopf A; Stark T; Schuler P; Hoffmann TK; Kojda G
Dtsch Med Wochenschr; 2010 May; 135(20):1027-31. PubMed ID: 20461661
[TBL] [Abstract][Full Text] [Related]
32. Urticaria and angioedema.
Spickett G
J R Coll Physicians Edinb; 2014; 44(1):50-4. PubMed ID: 24995449
[TBL] [Abstract][Full Text] [Related]
33. Angioedema.
Bork K
Immunol Allergy Clin North Am; 2014 Feb; 34(1):23-31. PubMed ID: 24262687
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel biomarkers to distinguish bradykinin-mediated angioedema from mast cell-/histamine-mediated angioedema.
Bindke G; Gehring M; Wieczorek D; Kapp A; Buhl T; Wedi B
Allergy; 2022 Mar; 77(3):946-955. PubMed ID: 34287950
[TBL] [Abstract][Full Text] [Related]
35. Angioedema.
Kaplan AP; Greaves MW
J Am Acad Dermatol; 2005 Sep; 53(3):373-88; quiz 389-92. PubMed ID: 16112343
[TBL] [Abstract][Full Text] [Related]
36. Managing Chronic Urticaria and Recurrent Angioedema Differently with Advancing Age.
Longhurst HJ; Gonçalo M; Godse K; Ensina LF
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2186-2194. PubMed ID: 33819638
[TBL] [Abstract][Full Text] [Related]
37. Hereditary and acquired complement component 1 esterase inhibitor deficiency: a review for the hematologist.
Cicardi M; Johnston DT
Acta Haematol; 2012; 127(4):208-20. PubMed ID: 22456031
[TBL] [Abstract][Full Text] [Related]
38. A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema.
Zuraw BL; Bernstein JA; Lang DM; Craig T; Dreyfus D; Hsieh F; Khan D; Sheikh J; Weldon D; Bernstein DI; Blessing-Moore J; Cox L; Nicklas RA; Oppenheimer J; Portnoy JM; Randolph CR; Schuller DE; Spector SL; Tilles SA; Wallace D; ;
J Allergy Clin Immunol; 2013 Jun; 131(6):1491-3. PubMed ID: 23726531
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-converting Enzyme Inhibitor and Other Drug-associated Angioedema.
Stone C; Brown NJ
Immunol Allergy Clin North Am; 2017 Aug; 37(3):483-495. PubMed ID: 28687104
[TBL] [Abstract][Full Text] [Related]
40. Fresh frozen plasma in the treatment of resistant angiotensin-converting enzyme inhibitor angioedema.
Warrier MR; Copilevitz CA; Dykewicz MS; Slavin RG
Ann Allergy Asthma Immunol; 2004 May; 92(5):573-5. PubMed ID: 15191027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
